phenytoin has been researched along with Cushing Syndrome in 12 studies
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The bioavailability of dexamethasone (DEX) has recently been demonstrated to be a critical factor in determining Dexamethasone Suppression Test (DST) status in psychiatric patients." | 1.27 | Dexamethasone bioavailability: implications for DST research. ( Lowy, MT; Meltzer, HY, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debrunner, J | 1 |
| Schmid, C | 1 |
| Schneemann, M | 1 |
| Aron, DC | 1 |
| Tyrrell, JB | 1 |
| Fitzgerald, PA | 1 |
| Findling, JW | 1 |
| Forsham, PH | 1 |
| Prinz, RA | 1 |
| Brooks, MH | 1 |
| Lawrence, AM | 1 |
| Paloyan, E | 1 |
| Birnberger, KL | 1 |
| Lowy, MT | 1 |
| Meltzer, HY | 1 |
| Leng, JJ | 1 |
| Greenblatt, RB | 1 |
| Schein, PS | 1 |
| Werk, EE | 2 |
| Thrasher, K | 1 |
| Choi, Y | 2 |
| Sholiton, LJ | 1 |
| Jubiz, W | 1 |
| Meikle, AW | 2 |
| Levinson, RA | 1 |
| Mizutani, S | 1 |
| West, CD | 2 |
| Tyler, FH | 2 |
| Stanchfield, JB | 1 |
| Black, M | 1 |
| Sholiton, L | 1 |
| Olinger, C | 1 |
| Haque, N | 1 |
12 other studies available for phenytoin and Cushing Syndrome
| Article | Year |
|---|---|
Falsely positive dexamethasone suppression test in a patient treated with phenytoin to prevent seizures due to nocardia brain abscesses.
Topics: Aged; Anticonvulsants; Brain Abscess; Cushing Syndrome; Dexamethasone; False Positive Reactions; Glu | 2002 |
Cushing's syndrome: problems in diagnosis.
Topics: ACTH Syndrome, Ectopic; Adenoma; Adrenal Cortex Function Tests; Adrenocortical Hyperfunction; Adult; | 1981 |
The continued importance of adrenalectomy in the treatment of Cushing's disease.
Topics: Adolescent; Adrenalectomy; Adult; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy; | 1979 |
[Myopathies. Possibilities of therapy].
Topics: Addison Disease; Cushing Syndrome; Humans; Muscular Diseases; Muscular Dystrophies; Myotonia Congeni | 1976 |
Dexamethasone bioavailability: implications for DST research.
Topics: Biological Availability; Carbamazepine; Cushing Syndrome; Depressive Disorder; Dexamethasone; Humans | 1987 |
Hirsutism in adolescent girls.
Topics: Adolescent; Adrenocortical Hyperfunction; Cobalt; Cortisone; Cushing Syndrome; Dexamethasone; Diazox | 1972 |
Islet cell tumors: current concepts and management.
Topics: Adenoma, Islet Cell; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Asparaginase; Child; Chil | 1973 |
Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Chromatography, Paper; Chrom | 1967 |
Effect of diphenylhydantoin on the metabolism of dexamethasone.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Adrenocortical Hyperfunction; Adrenocorticotropi | 1970 |
Hydrocortisone suppression test for Cushing syndrome. Therapy with anticonvulsants.
Topics: Adrenocorticotropic Hormone; Adult; Anticonvulsants; Corticosterone; Cushing Syndrome; Depression, C | 1974 |
Drugs and the liver.
Topics: Bilirubin; Cushing Syndrome; DDT; Enzyme Induction; Ethanol; Female; Humans; Hyperbilirubinemia; Inf | 1970 |
Interference in the effect of dexamethasone by diphenylhydantoin.
Topics: 17-Hydroxycorticosteroids; Cushing Syndrome; Dexamethasone; Female; Humans; Hydrocortisone; Phenytoi | 1969 |